Background: F. solani fungemia is unusual. Patients at risk are immunosuppressed, have underlying malignancy or severe debilitating diseases.
Methods: We report two cases of F. solani fungemia in two non neutropenic patients who had been treated with wide-spectrum antibiotics an/or systemic corticosteroids, parenteral nutrition and intravenous lines. Bactec NR-860 (Becton-Dickinson) system was used, and growth was detected in aerobic conditions (between 3-7 days of incubation).
Results: Removal of the catheters with or without i.v. amphotericin B were used successfully.
Conclusion: The spectrum of Fusarium sp. fungemia is discussed. Current available antifungal therapy is also reviewed.